gamma-DGG is used as a key intermediate in the synthesis of complex organic compounds, particularly in pharmaceutical research. It plays a role in developing drugs targeting neurological disorders due to its structural similarity to certain neurotransmitters, such as acting as a glutamate receptor antagonist. In biochemical studies, it serves as a precursor for investigating metabolic pathways, enzyme mechanisms, and neuroprotection against oxidative stress and toxins. It is also employed in research on learning, memory, and neurodegenerative diseases like Alzheimer's and Parkinson's.